DJIA 17,125.11 73.38 0.43%
NASDAQ 4,462.14 37.44 0.85%
S&P 500 1,983.76 10.13 0.51%
market minute promo

Impax Laboratories Inc. (NASDAQ: IPXL)

29.07 0.13 (0.45%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

IPXL $29.07 0.45%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $29.07
Previous Close $28.94
Daily Range $29.05 - $29.25
52-Week Range $19.39 - $31.04
Market Cap $2.0B
P/E Ratio 2,894.00
Dividend (Yield) $0.00 (0.0%)
Volume 42,228
Average Daily Volume 550,007
Current FY EPS $0.83

Sector

Healthcare

Industry

Drugs

Impax Laboratories Inc. (IPXL) Description

Impax Laboratories Inc. is a technology-based specialty pharmaceutical company focused on the development and commercialization of bioequivalent and brand-name pharmaceuticals utilizing its controlled-release and other in-house development. Website: http://www.impaxlabs.com/

News & Commentary

Is Teva's Situation Really So Dire?

Despite Teva’s poor performance recently, it still has several strong points that could revive its stock. How is Teva measuring up to Pfizer and Impax Laboratories?

Impax Laboratories (IPXL): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Impax Laboratories (IPXL): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Why Lannett Shares Are Down More Than 16%

Will Abbott Laboratories (ABT) Miss This Earnings Season? - Analyst Blog

6 companies that should report huge earnings gains

Impax Acquires Generic Products from Actavis - Analyst Blog

Impax Acquires Generic Products from Actavis - Analyst Blog

Trade-Ideas: Impax Laboratories (IPXL) Is Today's New Lifetime High Stock

Today In SA PRO: Monday, June 23

Wells Fargo Initiates Coverage On The Pharmaceutical Space

6 Stocks With High Days-To-Cover Ratios That Could Trap The Bears

Benzinga's Top Initiations

See More IPXL News...

IPXL's Top Competitors

IPXL $29.07 (0.45%)
Current stock: IPXL
JNJ $102.43 (1.15%)
Current stock: JNJ
NVS $89.15 (0.63%)
Current stock: NVS
RHHBY $36.92 (0.54%)
Current stock: RHHBY